



About
Allogeneic Solutions is dedicated to excellence in allograft distribution and places the highest value on our relationships. Our unwavering commitment to safety, clinical efficacy, and quality has enabled us to foster partnerships with leading innovators, providing access to a diverse range of advanced biologics. We take pride in offering regenerative medicine solutions that set new industry standards.
Strategically located in Atlanta, Georgia and the greater Reno, Nevada area. Allogeneic Solutions is ideally positioned to support Medical Professionals nationwide with a comprehensive range of brand-name biologics for amniotic membrane transplantation, surgical indications, sports medicine, and wound care.
Regenerative Medicine
Regenerative human cellular and tissue products, a category within human cellular and tissue-based products, refer to treatments that utilize living cells or tissues from humans to replace or repair damaged or diseased body parts. The FDA also refers to these products as human cellular and tissue-based products or (HCT/Ps).
The FDA has established comprehensive industry standards to monitor and regulate tissue transplant products, including stem cells, to ensure maximum patient safety. Cellular and tissue products that adhere to FDA-defined criteria are not classified as drugs but as HCT/P 361 products. While these products are FDA-regulated, they are not FDA-approved. When conducting HCT/P provider due diligence, prioritize organizations that have not warranted written interaction with the FDA.
RingBack Request
Ocular Defects
Amniotic membrane transplantation (AMT) involves the use of the innermost layer of the placenta, which is applied to ocular surfaces to support the body’s natural repair processes for corneal, conjunctival, and eyelid tissues following injury or disease. AMT serves as a protective covering during the recovery period.

